Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder-Reference-Cited by-同舟云学术

Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder

Published:2016-05 Issue:36 Volume: Page:e354-e366
ISSN:1548-8748
Container-title:American Society of Clinical Oncology Educational Book
language:en
Short-container-title:American Society of Clinical Oncology Educational Book

Author:

Batchelor Tracy T.¹,Thye Lim Soon¹,Habermann Thomas M.¹

Affiliation:

1. From the Division of Hematology/Oncology, Departments of Neurology and Radiation Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Department of Medical Oncology, National Cancer Centre, Duke-National University of Singapore Medical School, Singapore; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

Abstract

Primary central nervous system lymphoma, natural killer T-cell lymphoma nasal type, and post-transplant lymphoproliferative disorder are uncommon and complex lymphoproliferative disorders. These disorders present with different risk factors, have complex tumor characteristics, and require unique therapeutic interventions. These diseases require a multidisciplinary complex team approach. This article will update current management approaches and concepts.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

General Medicine

Link

https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_159030

Reference97 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

2. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma

3. Swerdlow SH, Campo E, Harris NL, et al (eds). WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008.

4. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma

5. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101;Blood Advances;2024-06-14

2. A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder;Frontiers in Neurology;2024-05-15

3. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches;World Journal of Transplantation;2020-02-28